Lessons learnt from establishing an Acute Oncology service. Dr. Pauline Leonard MD FRCP Consultant Medical Oncologist Whittington Health

Size: px
Start display at page:

Download "Lessons learnt from establishing an Acute Oncology service. Dr. Pauline Leonard MD FRCP Consultant Medical Oncologist Whittington Health"

Transcription

1 Lessons learnt from establishing an Acute Oncology service Dr. Pauline Leonard MD FRCP Consultant Medical Oncologist Whittington Health Over next 45 minutes.. Lessons learnt from: setting up a new service embedding a new service challenging traditional working practises Share the positive gains for an AOS Highlight the dynamics of an Acute Oncology Service 1

2 Rumsfeld principles... Known knowns NCAG 2009 NCEPOD 2008 National Patient safety alerts oral chemo Known unknowns Scale of the problem for each Trust/network Impact on current Oncology services Unknown unknowns Impact of doing things differently Both positive and negative A key recommendation from NCAG report 2009 Development of an Acute Oncology Service Management of patients who develop severe complications following chemo or as a consequence of their cancer Management of patients who present as emergencies with previously undiagnosed cancer AOS brings together expertise from oncology disciplines, emergency medicine, and general medicine and general surgery 2

3 What is an Acute Oncology Team? Emergency care medical & nursing staff Acute Medical on-take medical team Oncologist Palliative Care Clinical Nurse specialists Chemotherapy nurses AOS brings together expertise from oncology disciplines, emergency medicine, and general medicine and general surgery What is unscheduled care? Unscheduled or urgent care is care for those whose treatment is not planned in advance Examples in cancer Toxicity from treatment Diarrhoea Febrile neutropenia Symptoms from disease Pain Metastatic cord compression Patient with a previously undiagnosed cancer Medical and surgical emergencies not directly related to the underlying cancer 3

4 From the Patient perspective Accessing appropriate and skilled help when unwell Telephone advice Emergency services Delays in recognising complications of treatment or disease progression Timely antibiotics in febrile neutropenia Missed opportunities for intervention to prevent paraplegia in malignant spinal cord compression (MSCC) Poor experience of care Waiting in busy Emergency departments Wrong person sharing results Professional issues Limited access to clinical information on patient Especially out of hours Sometimes patients and their families unaware of prognosis Lack of specialist skills To recognise chemotherapy toxicities Ceilings of care not clear ITU or EOLC Organisational issues Pathways of care Education opportunities Challenging current culture 4

5 Lesson 1: Have a clear vision for an approach Be clear on what an Acute Oncology service is Working with those who deliver acute care to our patients Be accessible Share expertise Provide updated protocols Very clear on what is was not Oncologists in ED Clerking patients Carrying our interventional procedures Communicate experience from previous working practices Able to portray a better experience Attuned to current gaps Lesson 2: Define the role of Oncologist in AOS Sharing expertise in managing Oncological emergencies irrespective of tumour type Sub-specialisation has eroded confidence in generic skills Advisory capacity in how best to proceed in patients who present with a new suspected cancer Where case does not fit into recognised established pathways Individualised treatment plans incorporating PS & comorbidities 5

6 Be clear on what an Acute Oncology Service is not? Seeing patients with a past history of a resected cancer and now present with atrial fibrillation Seeing patients with a vague history and signs e.g. fatigue and anaemia with no clear clinical or radiological evidence of malignancy Acute Oncology should not supersede excellent diagnostic services but play a greater part in further management when malignancy suspected on radiology Lesson 3: Engage key stakeholders with your vision Set aside first 6 weeks after my appointment to meet all key staff from ED & AAU Spent day with Outreach critical care team to understand local landscape and issues Ensured I listened to feedback What was currently not good enough What needed fixing Stayed flexible around personal views My usual response is to solve Aim to deliver the shortfall 6

7 What did the acute clinicians want? Ready access to information on patients Chemo regimen given Treatment intention Patients to be better informed Admitted patients to be prioritised to Mercers Ward Approachable & accessible Oncology input Updated pathways on managing oncological emergencies Next steps Engaged with IM&T Setting up referral systems Setting up Rapid alert systems Discussed with Bed Managers Prioritising all admissions for patients with cancer to a designated medical ward Dr Leonard responsible for in-patient care Started a programme of Education ED Nurses Junior doctors & Medical Consultants 7

8 Used in house systems to bolt on referral systems Engaged with IM&T To set up referral systems using existing software E.g. order comms Sunquest ICE To set up Rapid alert systems To alert staff when known cancer patients on chemo present to ED With known bone mets present with back pain, weak legs Possible to use in house resources Used ACCESS database with PAS & Business Objects 8

9 9

10 Understand workforce available Scope existing expert personnel May already be doing the role without knowing it May have been waiting for a leader Biggest investment required is TIME Starting a new service on top of a busy timetable not do-able Sabbatical for 6 months versus a new appointment Advantages of having someone senior to engage Lesson 4: Data is King 10

11 Understand your local Oncology Landscape Cancer unit with a population 440,000 Within 3 miles of UCLH & RFH 583 new cancer diagnoses in 2008 at Whittington Majority referred via OPA 9.9% self-referred via ED Number of emergency medical admissions per day 30 (25-33) large seasonal variation 1-2 patients with cancer per day Data to understand the usual pathway King et al BMJ Qual Saf 2011;20: Process mapping the patient pathway for medical presentations 59% self referral Delay awaiting procedure Delay awaiting report Delay awaiting MDT A&E Admit Radiology report suggests cancer Refer for endoscopy/ biopsy for tissue diagnosis Cancer confirmed on histology MDT review imaging And histology Refer to oncology 41% GP referral 9 days 1.6 days 34 medical patients presented via ED 2008 and found to have a new cancer diagnosis Median Los 19 days Blood tests 42 Number of tests 3 47% referred to palliative care 26% Oncology 60% upper GI/HPB 11

12 GP/OP referral Two Week Wait Emergency presentation Other outpatient Screen detected Inpatient elective DCO Unknown Total Number of patients Relative one year survival: by cancer type Malignant registrations, South West 2007, excluding multiples and DCOs GP/OP referral (+TWW) Emergency Other route EUROCARE Cancer type Relative Relative Relative Relative 95% CIs 95% CIs 95% CIs Survival Survival Survival Survival Acute leukaemia 39.7 ( ) 39.4 ( ) 40.4 ( ) Bladder 78.3 ( ) 34.0 ( ) 79.2 ( ) 85.3 Brain & CNS 68.4 ( ) 34.0 ( ) 60.6 ( ) 39.1 Breast 97.7 ( ) 50.8 ( ) 98.2 ( ) 95 Colorectal 84.5 ( ) 48.4 ( ) 79.5 ( ) 74.7 Kidney 81.1 ( ) 24.0 ( ) 72.4 ( ) 74.7 Lung 39.8 ( ) ) 32.4 ( ) 36.1 Multiple myeloma 83.6 ( ) 53.1 ( ) 73.0 ( ) 70.5 Non-Hodgkin's lymphoma 86.6 ( ) 43.7 ( ) 80.9 ( ) 73.1 Oesophagus 43.8 ( ) 22.4 ( ) 45.5 ( ) 36.3 Other 81.1 ( ) 27.2 ( ) 77.8 ( ) Ovary 83.4 ( ) 38.8 ( ) 72.1 ( ) 70.7 Pancreas 21.0 ( ) 6.0 ( ) 22.3 ( ) 19.2 Prostate 98.0 ( ) 48.2 ( ) 98.3 ( ) 92.2 Stomach 49.1 ( ) 17.7 ( ) 47.6 (41-54) 44.1 Routes to Diagnosis Acute leukaemia 17% 3% 61% 12% 0% 4% 0% 4% 100% 380 Bladder 22% 36% 18% 13% 0% 6% 1% 5% 100% 1,167 Brain & CNS 18% 2% 49% 20% 0% 5% 0% 5% 100% 740 Breast 8% 40% 5% 5% 28% 2% 0% 13% 100% 5,646 Cervix 21% 17% 12% 8% 23% 3% 1% 15% 100% 308 Chronic leukaemia 26% 6% 45% 13% 0% 4% 1% 4% 100% 629 Colorectal 19% 29% 24% 12% 0% 8% 0% 7% 100% 4,515 Kidney 22% 26% 23% 16% 0% 5% 0% 8% 100% 928 Larynx 35% 34% 8% 14% 0% 5% 0% 3% 100% 216 Lung 15% 26% 38% 10% 0% 4% 1% 7% 100% 3,893 Melanoma 23% 39% 4% 8% 0% 5% 0% 22% 100% 1,686 Multiple myeloma 20% 14% 44% 13% 0% 4% 1% 5% 100% 606 Non-Hodgkin's lymphoma 25% 22% 25% 13% 0% 6% 1% 9% 100% 1,349 Oesophagus 15% 32% 21% 14% 0% 13% 0% 4% 100% 912 Oral 32% 27% 5% 14% 0% 4% 1% 17% 100% 458 Ovary 20% 29% 28% 11% 0% 3% 1% 8% 100% 853 Pancreas 13% 20% 45% 10% 0% 5% 1% 7% 100% 917 Prostate 26% 28% 11% 11% 0% 7% 0% 16% 100% 4,865 Stomach 14% 24% 31% 13% 0% 11% 1% 6% 100% 801 tbc (other) 21% 18% 34% 12% 0% 4% 1% 9% 100% 4,323 Testis 14% 47% 9% 15% 0% 4% 0% 11% 100% 259 Uterus 28% 36% 8% 12% 0% 5% 0% 12% 100% 918 Total 19% 28% 22% 11% 5% 5% 1% 10% 100% 36,369 All cancer Routes to Diagnosis: by cancer type All malignant registrations South West 2007 excluding C44 and multiples 12

13 Prospective audit of emergency admissions of cancer Dec 2012 March 2013 Cancer New ED diagnoses Total Dec Feb Percentage of diagnoses by ED (Dec Feb) National figure for percentage of diagnoses by ED (06-08) Examples of CUP pathways which ensure early triage to specific tumour MDT Lung % 39% Pancreas % 50% Hepatobiliary + GB % 48% NHL % 27% Myeloma % 37% MUO % 37% Gynae % 15% Colorectal % 26% CNS % 62% AML % 54% Bone sarcoma % 25% H&N- Oropharynx % 9% Mesothelioma % 36% Oesophagus % 22% Stomach % 33% Prostate % 10% Prospective audit of emergency admissions of cancer Dec 2012 March 2013 Cancer New ED diagnoses (RIP) Total Dec Feb Percentage of diagnoses by ED (Dec Feb) National figure for percentage of diagnoses by ED (06-08) Examples of CUP pathways which ensure early triage to specific tumour MDT Lung % 39% Pancreas % 50% Hepatobiliary + GB 3 (2) 5 60% 48% NHL % 27% Myeloma % 37% MUO % 37% Gynae % 15% Colorectal 2 (1) 14 14% 26% CNS % 62% AML 2 (1) 2 100% 54% Bone sarcoma % 25% H&N- Oropharynx % 9% Mesothelioma % 36% Oesophagus % 22% Stomach % 33% Prostate % 10% 13

14 Number of patients In-patient admissions during pilot Acute Oncology admissions to Mercers ward July- Dec Breast Lung CRC Upper GI HepBil Ovarian CUP Bladder Brain Other Treatment related Disease related Cancer type In-patient admissions to Mercers Ward 89 pts in 6 months - 78/89 = 88% disease related 7/89 = 8% treatment related 4/89 = 4% other 3 consecutive years audit data on unplanned admissions admitted under care of Dr Leonard Year (June December ) Type 2 known cancer treatment toxicities Type 3 known cancer progressive disease/symptom control 2009 (n=89) 8% (7) 88% (78) 2010 (n=42) 17% (7) 83% (35) 2011 (n=18) 17% (3) 83% (15) Total 17 (12%) 128 (88%) 14

15 The Acute Oncology service and admissions to Mercers ward Admission secondary to treatment related toxicity e.g. febrile neutropenia Admission secondary to symptom related to disease e.g. bone pain, increasing ascites End of life care episode Admission caused by medical event e.g. PE, UTI, fast AF, TIA, chest infection etc Known cancer patients (Dr Leonard) If admitted to Mercers Dr Leonard will take over care over If admitted to Mercers Dr Leonard will take over care over If admitted to Mercers Dr Leonard will take over care over To remain under care of admitting physician please inform Dr Leonard Known cancer patients (other Oncologist) If admitted to Mercers Dr Leonard will take over care over If admitted to Mercers Dr Leonard will take over care over To remain under care of admitting physician please involve Palliative care team To remain under care of admitting physician Dr Leonard & AOS happy to give advice re:ceiling of care if appropriate Previously undiagnosed Cancer patient To remain under care of admitting physician please refer to Dr Leonard & AOS via ICE To remain under care of admitting physician please involve Palliative care team To remain under care of admitting physician Dr Leonard & AOS happy to give advice re:ceiling of care if appropriate Lesson 5: Embedding the service 15

16 Reach all health care professionals A study or induction day is not enough High turnover of staff All levels needed to be engaged Consultants are territorial and set in their ways Repetitive & consistent Grand rounds FY1/2 teaching core trainee ST At the bedside 16

17 Introducing new pathways of care The Gatekeepers are the Radiologists Referral direct from Cons Radiologist 35 yr old female 6m history back pain & lethargy GP referred for CT on basis of abnormal CXR Called on day of CT to explain Within 24 hrs mediastinoscopy Within 4 working days diagnosis HD 17

18 MR WM 71yrs Non-smoker Hx RUQ pain GP rang for advice liver mets on US Seen by PL Fast track OPA (4/7) PS 1 Keen for all interventions understood treatment plan and intention CT results & diagnostic plan (11/7) EBUS UCLH (12/7) MDT presentation on (14/7) EBUS results & 1 st day treatment (21/7) Lung MDT presentation (26/7) Compare & contrast Fast track v Best 2WW MR WM 71yrs Non-smoker Hx RUQ pain GP rang for advice liver mets on US Seen by PL Fast track OPA (4/7) PS 1 Keen for all interventions understood treatment plan and intention CT results & diagnostic plan (11/7) EBUS UCLH (12/7) Unkown Primary MDT presentation (21/7) EBUS results & 1 st day treatment (21/7) Lung MDT presentation (26/7) MR WM 71yrs Non-smoker Hx RUQ pain GP sends 2WW - liver mets on US Seen by Gastro team (14/7) PS 1 Keen for all interventions understood treatment plan and intention CT results & discussion at unknown primary MDT (21/7) Outcome refer Lung MDT MDT discussion - outcome refer EBUS UCLH (26/7) EBUS UCLH (33/7) MDT presentation (40/7) PL Onco clinic & 1 st day treatment P a t i e n t e x p e r i e n c e (46/7) 18

19 Traditional pathway same outcome GP U/S Peritoneal cake CT done same day MUO MDT (D2) PL rang GP to offer fast-track OPA for assessment on yrs female Short history fatigue, nausea & reduced appetite (D6) Informed by GP for PP Saw HPB surgeon - biopsy Meets PL (D23) PS 2 Doesn t want chemo GFR 29 mls/min Dex & community Pall care 19

20 Early AOS can improve experience of care-celebration of generic skills 28 yrs female 6m history back pain Abnormal x-ray reported & orthopaedic team alerted MRI pelvis & CT Thorax/Abdo done AOS involved Seen at RNOH Sarcoma MDT Prof Whelan no chemo RIP Liver metastases only How do we manage this case? -determine fitness -PS -renal & liver function -assess symptoms -explore wishes -Biopsy if chemo appropriate 20

21 Why do clinicians over investigate? Fear of missing the treatable? Unwillingness that CUP is advanced disease? Do something is easier than having an honest discussion about poor prognosis? Belief that histological diagnosis a stronger determinant than prognosis determined by PS/co-morbidities Metastatic Spinal cord compression 59yrs female Short history of weakness & loss of sensation right hand with pain in neck Contacted directly by MRI Vertebral collapse C7, T1,T2 & T3 with impending cord compression Organised by phone urgent RT & team approach Patient transferred UCLH and treated Post RT biopsy Metastatic breast ca 21

22 75% of all presentations of MSCC are from Breast, Lung & Prostate 5-10% will be myeloma or lymphoma Total number of AOS admissions proportion referred via ICE (blue) April October

23 23

24 ED alerts April March alerts 651/1171 (55%) admitted Cf 2009/ % Cf 2010/11 64% Cancer type Numbers admitted CRC 153 Lung 138 Breast 114 Prostate 46 Oesophageal 35 Gastric 12 Bladder 8 Ovarian 6 Pancreatic 6 Melanoma 4 Example of Rapid alert changing management 40 yrs male Completed neoadjuvant chemo for synchronous sigmoid & liver CRC 4 weeks post hepatic resection Presented ED with headache over weekend 24

25 Updated algorithim NICE

26 26

27 Summary of patients who presented with FN in a 6 month period in 2011 Patient ED Arrival time ED Triage time Medical assessment time Time Tazocin given Time gentamicin given 60 min pathway time met Y N Cipro N Need to ensure antibiotics to be given by ED team in resus 27

28 Collaborating with other teams Patient Specific Protocols Individualised Consent Involve the patient and the entire treatment team LAS Letterhead Medical Director s signature London Ambulance Service NHS Trust 56 28

29 Headline data from pilot Pilot ran from patients treated with chemo 63 assessed as high risk 18/63 (29%) admitted via ED 14/18 were on chemotherapy 6/14 (55%) confirmed FN (3.4% of all patients treated) 10/14 on chemo Ca Breast ( 7/10 FEC-T - curative) 3/14 Lung 1/14 Neoadjuvant GOJ Small proportion of all treated door to needle time improved with PSP Results Pilot 24/7 telephone helpline Pilot time 30 th July 21 st October treatment episodes Rota with each participant taking a week Mon -Sun 64 calls ( 37% pts treated) 65% hrs Monday Friday 42% hrs 21% Weekend 14% hrs anytime 29

30 Careful provision of care by teams who communicate well How do we communicate? One point of referral for AOT (electronic system) All referrals triaged daily by Dr Leonard/Dr Mohamed & AOS CNS Refer to Palliative Care Refer to Haematology Dr Leonard, Dr Mohamed or AOS CNS to review Refer to site specific CNS All suspected and/or confirmed cancer cases are discussed at site specific or malignancy unknown MDT 30

31 The Whitt MUO referral pathway PS = Performance Status AOS = Acute Oncology Service AOT = Acute Oncology team MUO= Malignancy unknown origin OPA = out-patient appointment Patient presents as an emergency with alarm symptoms or suspicious imaging Make a decision to admit or fast track to OPA assessment Communicate suspicion of cancer Needs admission Assess PS 0-1 or >2 Measure renal & liver function Determine patient preferences for possible treatment interventions Arrange discharge NO obvious primary site or unclear if fit for further intervention book to fast track AOS OPA within week Clear primary site refer site specialist team for OPA Good PS & fit and willing for further interventions refer site specific or MUO MDT involve AOT to help tailor timely & appropriate investigations Poor or borderline PS/comorbidities/patient or physician unsure refer AOS within 24hrs of suspicious scan Refer MUO or site specific MDT for completeness OPA review Good PS with good renal, haem & liver function & willing to undergo biopsy arrange biopsy of site which maximises staging information if unclear from imaging Refer MUO MDT What could be the benefits of embedding comprehensive AOS Improved patient experience Improved patient outcomes Equipping on-call teams with AOS training & updated protocols to : Achieve door to needle time of 60 minutes in patients with FN Referral of appropriate patients for neurosurgical opinion in MSCC Up skilling all front-line staff to recognise the emergency and manage appropriately Lending expertise Avoid duplication of resources Improve efficiency of services Timely assessment after admission from experienced Oncologist can ensure the most appropriate in management is undertaken More satisfied patients (and staff!!) Reduced length of stay 31

32 Overcoming challenges Engage and share vision Ensure all key stakeholders are involved Collect data Only way to challenge perception Listen To all feedback Reflect When things have not gone so well Stay responsive and dynamic Service needs change Ensure you have authority to deliver change 32

How a fully integrated Acute Oncology Service can benefit the busy medical unit

How a fully integrated Acute Oncology Service can benefit the busy medical unit How a fully integrated Acute Oncology Service can benefit the busy medical unit Dr. Pauline Leonard MD FRCP Consultant Medical Oncologist Whittington Health Over the next 35 mins Briefly remind you of

More information

How an Acute Oncology service can help with managing Cancer of unknown primary

How an Acute Oncology service can help with managing Cancer of unknown primary How an Acute Oncology service can help with managing Cancer of unknown primary Dr Pauline Leonard MD FRCP Consultant Medical Oncologist Lead Cancer Clinician Whittington Health Definitions Patients who

More information

Acute Oncology Martin Eatock Consultant Medical Oncologist NICaN Medical Director

Acute Oncology Martin Eatock Consultant Medical Oncologist NICaN Medical Director Acute Oncology 2014 Martin Eatock Consultant Medical Oncologist NICaN Medical Director Patients admitted with cancer have a longer than average stay Berger et al. Clin Medicine (2013) Questions If your

More information

Acute Oncology: Service Provision in Smaller Cancer Centres Ernie Marshall Clatterbridge Centre for Oncology

Acute Oncology: Service Provision in Smaller Cancer Centres Ernie Marshall Clatterbridge Centre for Oncology Acute Oncology: Service Provision in Smaller Cancer Centres Ernie Marshall Clatterbridge Centre for Oncology Whiston Hospital St Helen s Hospital 350,000 population ~1000 beds Regional Plastics Unit DGH

More information

What is Acute Oncology? Kay McCallum Acute Oncology Advanced Nurse Practitioner John Radcliffe Hospital Oxford September 2015

What is Acute Oncology? Kay McCallum Acute Oncology Advanced Nurse Practitioner John Radcliffe Hospital Oxford September 2015 What is Acute Oncology? Kay McCallum Acute Oncology Advanced Nurse Practitioner John Radcliffe Hospital Oxford September 2015 What is Acute Oncology? Outline of Talk Concept of Acute Oncology Service (AOS)

More information

Referral guide for acute oncology emergencies

Referral guide for acute oncology emergencies Referral guide for acute oncology emergencies 1 st Edition v 1.0 London Cancer March 2013 To be used in conjunction with London Cancer clinical guidelines for acute oncology emergencies; A Guide to Acute

More information

Unknown Primary Service for patients at Chesterfield Royal Hospital

Unknown Primary Service for patients at Chesterfield Royal Hospital Unknown Primary Service for patients at Chesterfield Royal Hospital David Brooks Macmillan Consultant in Palliative Medicine Louise Merriman GP Cancer Lead With thanks to Macmillan Cancer Support, who

More information

Cancer of Unknown Primary (CUP) Protocol

Cancer of Unknown Primary (CUP) Protocol 1 Department of Oncology. Cancer of Unknown Primary (CUP) Protocol Version: Document type: Document sponsor Designation Document author [ s] Designation[s] Approving committee / Group Ratified by: Date

More information

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes Cancer and Data in the New NHS May 2011 Di Riley, Director Clinical Outcomes Overarching NHS context Financial constraints White Paper GP Commissioning/Commissioning Board Public Health England National

More information

LCA Lung Clinical Forum. 21 st October 2014

LCA Lung Clinical Forum. 21 st October 2014 LCA Lung Clinical Forum 21 st October 2014 Welcome Dr Liz Sawicka Chair - LCA Lung Pathway Group Succession planning Dr Kate Haire Consultant in Public Health Medicine, LCA Commissioning Intentions for

More information

National Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer

National Optimal Lung Cancer Pathways. Dr Sadia Anwar Nottingham University Hospitals NHS Trust Clinical Lead for Lung Cancer National Optimal Lung Cancer Pathways Dr Sadia Anwar ttingham University Hospitals NHS Trust Clinical Lead for Lung Cancer Overview How NOLCP evolved How it relates to national guidance Pathways Implementation

More information

Palliative care - the opportunities. Dr David Brooks Macmillan Consultant in Palliative Medicine Chesterfield Royal Hospital

Palliative care - the opportunities. Dr David Brooks Macmillan Consultant in Palliative Medicine Chesterfield Royal Hospital Palliative care - the opportunities Dr David Brooks Macmillan Consultant in Palliative Medicine Chesterfield Royal Hospital Our Commitment to you for end of life care The Government Response to the

More information

National Optimal Lung Cancer Pathway

National Optimal Lung Cancer Pathway National Optimal Lung Cancer Pathway This document was produced by the Lung Clinical Expert Group 2017 Document Title: National Optimal Lung Cancer Pathway and Implementation Guide Date of issue: August

More information

Identifying and counting people living with treatable but not curable cancer

Identifying and counting people living with treatable but not curable cancer Identifying and counting people living with treatable but not curable cancer Rachel White Joanna Pethick, Archie Macnair, Gregory Fallica, Jennifer Than and Jane Maher September 2018 Who are the people

More information

Cancer of Unknown Primary Service

Cancer of Unknown Primary Service Cancer of Unknown Primary Service Dr Maurice Fernando Consultant In Specialist Palliative Care and CUP lead Doncaster and Bassetlaw Hospitals NHS FT Wakefield meeting -14-07-2016 CUP service CUP MDT

More information

North of Scotland Cancer Network: Horizon Scanning Report for NoSPG Peter Gent & Mr Peter King North of Scotland Cancer Network

North of Scotland Cancer Network: Horizon Scanning Report for NoSPG Peter Gent & Mr Peter King North of Scotland Cancer Network North of Scotland Cancer Network: Horizon Scanning Report for NoSPG Peter Gent & Mr Peter King North of Scotland Cancer Network Introduction Cancer Incidence & Projected Trends National ISD reported that

More information

Acute Oncology Induction Training Specification

Acute Oncology Induction Training Specification Acute Oncology Induction Training Specification Author: Acute Oncology/Cancer of Unknown Primary Clinical Network Group (AO/CUP CNG) V. 2.0 Agreed: 30.11.2012 Reviewed: May 2015 Review : May 2016 MCCN

More information

David Brooks Macmillan Consultant in Palliative Medicine

David Brooks Macmillan Consultant in Palliative Medicine Developing a new pathway for CUP patients at Chesterfield Royal Hospital David Brooks Macmillan Consultant in Palliative Medicine Philippa Hughes, Claire Farrington, Bill Noble, Peter Bath, Lingesan Gokulkrishnan,

More information

PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE

PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE PATHWAY MANAGEMENT OF METASTATIC SPINAL CORD COMPRESSION (MSCC) THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: Dr V. Misra Version: Accountable Committee: V3 MSCC Network

More information

National Standards for Acute Oncology Services

National Standards for Acute Oncology Services Cancer National Specialist Advisory Group National Standards for Acute Oncology Services June 2016 TABLE OF CONTENTS 1. PURPOSE... 2 2. INTRODUCTION... 2 3. STRATEGIC CONTEXT... 4 4. SCOPE OF ACUTE ONCOLOGY

More information

NICE Quality Standards and COF

NICE Quality Standards and COF NICE Quality Standards and COF David Baldwin Consultant Respiratory Physician NUH Hon Senior Lecturer Nottingham University Clinical lead NICE lung cancer GL Chair NICE QS Topic Expert Group Quality Standards

More information

Neutropenic Sepsis Acute General Management and Support. Ernie Marshall Macmillan Consultant in Medical Oncology Clatterbridge Centre for Oncology

Neutropenic Sepsis Acute General Management and Support. Ernie Marshall Macmillan Consultant in Medical Oncology Clatterbridge Centre for Oncology Neutropenic Sepsis Acute General Management and Support Ernie Marshall Macmillan Consultant in Medical Oncology Clatterbridge Centre for Oncology Who Am I? I am A Medical Oncologist (MCCN) Site specialist

More information

Dr Hilary Williams. Consultant in Medical Oncology at Velindre Cancer Centre

Dr Hilary Williams. Consultant in Medical Oncology at Velindre Cancer Centre Dr Hilary Williams. Consultant in Medical Oncology at Velindre Cancer Centre Hilary.williams4@wales.nhs.uk Thinking about Acute Oncology. Why do we need acute oncology locally? What the Hub VCC provides

More information

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease

PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES. U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease PATHWAY FOR INVESTIGATION OF ADULTS PRESENTING WITH ASCITES U/S Abdo/pelvis shows ascites without obvious evidence of 1 liver disease Refer back to original requester with this paperwork and review previous

More information

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree

Update on Management of Malignant Spinal Cord Compression. Heino Hugel Consultant in Palliative Medicine University Hospital Aintree Update on Management of Malignant Spinal Cord Compression Heino Hugel Consultant in Palliative Medicine University Hospital Aintree Current Guidelines The symptoms of MSCC may be subtle and therefore careful

More information

Cancer of Unknown Primary (CUP)

Cancer of Unknown Primary (CUP) Cancer of Unknown Primary (CUP) Pathways and Guidelines V1.0 London Cancer September 2013 The following pathways and guidelines document has been compiled by the London Cancer CUP technical subgroup and

More information

Cancer Improvement Plan Update. September 2014

Cancer Improvement Plan Update. September 2014 Cancer Improvement Plan Update September 2014 1 Contents Page 1. Introduction 3 2. Key Achievements 4-5 3. Update on Independent Review Recommendations 6-13 4. Update on IST Recommendations 14-15 5. Update

More information

Metastatic Spinal Cord Compression (MSCC) Clinical guidelines and pathway

Metastatic Spinal Cord Compression (MSCC) Clinical guidelines and pathway Metastatic Spinal Cord Compression (MSCC) Clinical guidelines and pathway Version 2: May 2012 To be read in conjunction with NICE CG75 Developed by consensus by: Dr Peter Robson, Consultant Oncologist,

More information

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes

Cancer and Data in the New NHS May Di Riley, Director Clinical Outcomes Cancer and Data in the New NHS May 2011 Di Riley, Director Clinical Outcomes Alignment with NHS reforms Improving outcomes: A strategy for cancer sets out how the future direction for cancer will be aligned

More information

Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres

Greater Manchester Commissioning Hub: Cancer Programme. The ACE Programme. Wave 2 Multidisciplinary Diagnostic Centres Greater Manchester Commissioning Hub: Cancer Programme The ACE Programme Wave 2 Multidisciplinary Diagnostic Centres Background / Context GM Pilot focuses on 2 areas of Greater Manchester: Oldham South

More information

MSCC CARE PATHWAYS & CASE STUDIES. By Michael Balloch Spine CNS

MSCC CARE PATHWAYS & CASE STUDIES. By Michael Balloch Spine CNS MSCC CARE PATHWAYS & CASE STUDIES By Michael Balloch Spine CNS Aims To be familiar with the routes of MSCC prentaion How the guidelines work in practice Routes of presentation Generic intervention Managing

More information

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician ASWCN TAUNTON AND SOMERSET Taunton Lung MDT (11-2C-1) - 2011/12 Dr Sarah Foster Compliance Self Assessment LUNG MDT

More information

Ambulatory lung biopsy: a new model for the NHS. Dr Sam Hare Barnet Hospital Royal Free London NHS Trust

Ambulatory lung biopsy: a new model for the NHS. Dr Sam Hare Barnet Hospital Royal Free London NHS Trust Ambulatory lung biopsy: a new model for the NHS Dr Sam Hare Barnet Hospital Royal Free London NHS Trust Lung cancer Leading cause of UK cancer mortality UK: 2 nd lowest European survival rate 62-day RTT

More information

There are a number of national guidelines and performance standards which support the implementation of a straight to CT pathway.

There are a number of national guidelines and performance standards which support the implementation of a straight to CT pathway. December 2015 CONTENTS Contents... 2 1 Introduction... 3 2 Case for Change... 3 3 Evidence... 3 3.1 National and regional policy... 3 3.2 Local audit... 4 4 Supporting Work Initiatives... 5 4.1 Identification

More information

Cancer in the South West Peninsula - a baseline assessment

Cancer in the South West Peninsula - a baseline assessment Cancer in the South West Peninsula - a baseline assessment 1 The Cancer Reform Strategy 1.1 The Cancer Reform Strategy, published in December 2007 1, built on the progress already achieved since the publication

More information

NCIN Conference Feedback 2015

NCIN Conference Feedback 2015 NCIN Conference Feedback 2015 Parallel Sessions Treatments (Black type is the topic; blue type are comments) The use of population and research data in the development of guidelines for cancer treatment

More information

How can we facilitate cross-boundary working in Greater Manchester?

How can we facilitate cross-boundary working in Greater Manchester? How can we facilitate cross-boundary working in Greater Manchester? Emma Halkyard Nurse Clinician Cross boundary working: where are we now? Our patients are complex Our pathways are complex Our treatments

More information

COSD & Source of Referral

COSD & Source of Referral COSD & Source of Referral A Brief guide October 2014 Michael Sharpe Data Improvement Manager National Cancer Registration Service What is COSD? Cancer and Outcomes Services Dataset Clinical dataset for

More information

Faster Cancer Treatment Indicators: Use cases

Faster Cancer Treatment Indicators: Use cases Faster Cancer Treatment Indicators: Use cases 2014 Date: October 2014 Version: Owner: Status: v01 Ministry of Health Cancer Services Final Citation: Ministry of Health. 2014. Faster Cancer Treatment Indicators:

More information

North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO)

North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO) North of Scotland Cancer Network Clinical Management Guideline for Metastatic Malignancy of Undefined Primary Origin (MUO) UNCONTROLLED WHEN PRINTED DOCUMENT CONTROL Original Prepared by NMcL April 2016

More information

Lung cancer timed clinical pathways

Lung cancer timed clinical pathways Lung cancer timed clinical pathways December 2017 1 Context This document sets out best practice timed clinical pathways for lung cancer. It is anticipated that all Cancer Alliances will audit against

More information

Early Diagnosis: Serious but non-specific symptom pathway

Early Diagnosis: Serious but non-specific symptom pathway Early Diagnosis: Serious but non-specific symptom pathway Lily Megaw Becky Gokce Karen Fitzgerald Geraint Jones Luigi de Michele Arun Takhar Introduction Lily Megaw This is a five year programme Based

More information

CP80 Version: V01. Acute Oncology Management Service Date approved: 8 th May 2015 Date ratified: 1 st June 2015 Review date: 1 st June 2017

CP80 Version: V01. Acute Oncology Management Service Date approved: 8 th May 2015 Date ratified: 1 st June 2015 Review date: 1 st June 2017 STANDARD OPERATING PROCEDURE (SOP) AND PATHWAY FOR THE MANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION (MSCC) WITHIN THE CHRISTIE (Refer to the Manchester Cancer Network MSCC Pathway flowchart)

More information

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician GMCN ROYAL WOLVERHAMPTON HOSPITALS The Royal Wolverhampton Hospitals Trust Lung MDT (11-2C-1) - 2011/12 Dr Angela Morgan

More information

CIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board)

CIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board) CIG SCP Health Board/Velindre Implementation Plan (Aneurin Bevan University Health Board) 1 Governance, Leadership and Planning a) Describe your SCP Programme Board (or equivalent), its membership and

More information

Delivering 62 Day GP Cancer Waits in a Complex Landscape. Hannah Marder Cancer Manager University Hospitals Bristol

Delivering 62 Day GP Cancer Waits in a Complex Landscape. Hannah Marder Cancer Manager University Hospitals Bristol Delivering 62 Day GP Cancer Waits in a Complex Landscape Hannah Marder Cancer Manager University Hospitals Bristol Overview The 62 day GP target Cancer pathways What causes breaches? Good practice and

More information

Acute Oncology Services Clinical Forum: Metastatic Spinal Cord Compression. Tuesday 17 th September 2013

Acute Oncology Services Clinical Forum: Metastatic Spinal Cord Compression. Tuesday 17 th September 2013 Acute Oncology Services Clinical Forum: Metastatic Spinal Cord Compression Tuesday 17 th September 2013 Welcome, Introduction and Aims of the Event Dr Tom Newsom-Davis, LCA AOS Pathway Chair Why MSCC?

More information

Haemato-oncology Clinical Forum. 20 th June 2013

Haemato-oncology Clinical Forum. 20 th June 2013 Haemato-oncology Clinical Forum 20 th June 2013 Welcome Dr Majid Kazmi, LCA Haemato-oncology Pathway Group Chair Purpose of today Provide an update on progress of the LCA to date Identify priorities for

More information

Vacancy list Pathway Boards

Vacancy list Pathway Boards Vacancy list Pathway Boards The table below includes all the current vacancies for Pathway Boards. If you would like to apply to be a patient and carer representative on a Pathway Board, you need to have

More information

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018

SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018 SCOTTISH CANCER REFERRAL GUIDELINES REVIEW 2018 Dr Peter Hutchison, Chair of Review Group WHAT & WHY? Scottish Cancer Referral Guidelines 2014 Scottish Primary Care Cancer Group identified need for some

More information

West Midlands Sarcoma Advisory Group

West Midlands Sarcoma Advisory Group West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Specialist Sarcoma Multi Disciplinary Team for Suspected Bone Sarcoma Version History Version Date Brief Summary

More information

Cancer Outcomes and Services Dataset: Implications for clinical teams

Cancer Outcomes and Services Dataset: Implications for clinical teams Cancer Outcomes and Services Dataset: Implications for clinical teams Mick Peake Clinical Lead, NCIN National Clinical Lead, NHS Cancer Improvement Consultant & Senior Lecturer in Respiratory Medicine,

More information

St. Joseph s Regional Thoracic Program. Dr. Yaron Shargall (Head, Thoracic Surgery) St. Joseph s Healthcare Hamilton

St. Joseph s Regional Thoracic Program. Dr. Yaron Shargall (Head, Thoracic Surgery) St. Joseph s Healthcare Hamilton St. Joseph s Regional Thoracic Program Dr. Yaron Shargall (Head, Thoracic Surgery) St. Joseph s Healthcare Hamilton SJHH REGIONAL THORACIC PROGRAM Collaboration & Integration Thoracic Surgery - Malignant

More information

MDT IMPROVEMENT PROJECT. Professor Muntzer Mughal, UCLH

MDT IMPROVEMENT PROJECT. Professor Muntzer Mughal, UCLH MDT IMPROVEMENT PROJECT Professor Muntzer Mughal, UCLH 1995..assessment and management of rare cancers in multidisciplinary teams.. 2000 the care of all patients with cancer should be formally reviewed

More information

Cancer of Unknown Primary (CUP)

Cancer of Unknown Primary (CUP) Cancer of Unknown Primary (CUP) Information for patients This information is for people with cancer of unknown primary (CUP) and covers symptoms, investigations/tests and treatment options. If there is

More information

MANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION

MANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION CLINICAL POLICY MANAGEMENT OF PATIENTS WITH METASTATIC SPINAL CORD COMPRESSION DOCUMENT REF: PCLASCORD (Version No. 1.4) Name and designation of policy author(s) Approved by (committee, group, manager)

More information

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU.

A Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU. Subject: Neutropenic Fever Guideline for Junior Doctors Date of Implementation: January 2010 Date of Review: January 2012 Director Responsible for Implementation and Review: Policy location: Consultant

More information

Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases

Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases Manchester Cancer Colorectal Pathway Board: Guidelines for management of colorectal hepatic metastases Date: April 2015 Date for review: April 2018 1. Principles The recognised specialist HPB MDT for Greater

More information

London Strategic Clinical Networks. Quality Standard. Version 1.0 (2015)

London Strategic Clinical Networks. Quality Standard. Version 1.0 (2015) London Strategic Clinical Networks Quality Standard Version 1.0 (2015) Supporting the delivery of equitable, high quality AKI care through collaboration www.londonaki.net @LondonAKI Overview The management

More information

Supra Network Sarcoma Advisory Group (SAG) Annual Report

Supra Network Sarcoma Advisory Group (SAG) Annual Report London and South East Sarcoma Network Supra Network Sarcoma Advisory Group (SAG) Annual Report 2011-2012 Hosted by Date: December 2012 Version: 2 Review Date: September 2013 London Cancer Integrated Cancer

More information

Recognition & Treatment of Malignant Spinal Cord Compression Study Day

Recognition & Treatment of Malignant Spinal Cord Compression Study Day Recognition & Treatment of Malignant Spinal Cord Compression Study Day 11 th May 2017 Dr Bernie Foran Consultant Clinical Oncologist & Honorary Senior Lecturer Weston Park Hospital Outline of Talk Clinical

More information

SOUTH THAMES CHILDREN S CANCER NETWORK GROUP. REFERRAL PROTOCOLS AND DIAGNOSIS AND STAGING PROTOCOLS October 2014

SOUTH THAMES CHILDREN S CANCER NETWORK GROUP. REFERRAL PROTOCOLS AND DIAGNOSIS AND STAGING PROTOCOLS October 2014 SOUTH THAMES CHILDREN S CANCER NETWORK GROUP REFERRAL PROTOCOLS AND DIAGNOSIS AND STAGING PROTOCOLS October 2014 Contents 1. Leukaemia Referral, Diagnostic and Staging Guidelines 2. Lymphoma Referral,

More information

Improving services for upper GI (OG) cancer Application template (Version 2)

Improving services for upper GI (OG) cancer Application template (Version 2) Trust Clinical lead Improving services for upper GI (OG) cancer Application template (Version 2) Managerial lead Date completed 14 June 2013 Barnet & Chase Farm Hospitals NHS Trust Dr Marta Carpani Upper

More information

Acute Oncology. Protocols & Competencies Acute Oncology Introduction

Acute Oncology. Protocols & Competencies Acute Oncology Introduction Acute Oncology Protocols & Competencies Acute Oncology Introduction Acute Oncology elearning Module Throughout the Acute Oncology FACTS elearning courses you will be able to access Network Protocols by

More information

Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway

Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway Dr Alex Williams, Oncology Specialty Doctor. Cheltenham General Hospital Oncology Centre

More information

DEPARTMENT OF ONCOLOGY ELECTIVE

DEPARTMENT OF ONCOLOGY ELECTIVE DEPARTMENT OF ONCOLOGY ELECTIVE 2015-2016 www.uwo.ca/oncology Oncology Elective Program Administrator: Ms. Kimberly Trudgeon Room A4-901C (Admin) LHSC London Regional Cancer Centre (Victoria Campus) Phone:

More information

Improving diagnostic pathways for patients with vague symptoms

Improving diagnostic pathways for patients with vague symptoms Improving diagnostic pathways for patients with vague symptoms Executive summary Accelerate, Coordinate, Evaluate (ACE) Programme An early diagnosis of cancer initiative supported by: NHS England, Cancer

More information

Work Programme/Service Delivery Plan 2010/2013

Work Programme/Service Delivery Plan 2010/2013 Essex and East Suffolk Gynaecological Cancer Network Site Specific Group Work Programme/Service Delivery Plan 2010/2013 Version Number 1.2 Author Members of the NSSG Date Written June 2010 Reviewed May

More information

BRIEFING PAPER THE USE OF RED FLAGS TO IDENTIFY SERIOUS SPINAL PATHOLOGY THE CHRISTIE, GREATER MANCHESTER & CHESHIRE. Version:

BRIEFING PAPER THE USE OF RED FLAGS TO IDENTIFY SERIOUS SPINAL PATHOLOGY THE CHRISTIE, GREATER MANCHESTER & CHESHIRE. Version: BRIEFING PAPER THE USE OF RED FLAGS TO IDENTIFY SERIOUS SPINAL PATHOLOGY THE CHRISTIE, GREATER MANCHESTER & CHESHIRE Procedure Reference: Document Owner: Jackie Turnpenney Version: Accountable Committee:

More information

A research briefing paper by Macmillan Cancer Support

A research briefing paper by Macmillan Cancer Support A research briefing paper by Macmillan Cancer Support Introduction Key findings 3 People with cancer are surviving longer 4 Median survival time has seen dramatic improvement for some cancers 5 Median

More information

National Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator

National Cancer Peer Review Sarcoma. Julia Hill Acting Deputy National Co-ordinator National Cancer Peer Review Sarcoma Julia Hill Acting Deputy National Co-ordinator Improving Outcomes Guidance The Intentions of Improving Outcomes for People with Sarcoma Changes in the provision of care

More information

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM) Network Trust MDT MDT Lead Clinician NECN NORTH TEES AND HARTLEPOOL North Tees And Hartlepool Lung MDT (11-2C-1) - 2011/12 Dr D N Leitch Compliance Self

More information

INTRODUCTION PROBLEM OBJECTIVE

INTRODUCTION PROBLEM OBJECTIVE Mount Vernon Cancer Network Delivering a systematic approach to dealing with Cancer related emergencies (Acute Oncology) across the Mount Vernon Cancer Network, which meets the recommendations set out

More information

Streamlining the lung diagnostic pathway (A87)

Streamlining the lung diagnostic pathway (A87) Streamlining the lung diagnostic pathway (A87) Crawley CCG with Surrey and Sussex Healthcare NHS Trust Evaluation January 2017 Summary A new Straight-to-CT pathway for patients with an abnormal CXR result

More information

Acute Oncology & Chemotherapy Clinical Network Group (CNG)

Acute Oncology & Chemotherapy Clinical Network Group (CNG) Acute Oncology & Chemotherapy Clinical Network Group (CNG) Work Programme 2014-2015 Version 1.0 This Work Programme has been agreed by: Title Name Date Agreed AO & Chemotherapy CNG Chair Ernie Marshall

More information

Palliative Care Emergencies

Palliative Care Emergencies Palliative Care Emergencies LAURA BARNFIELD What might constitute an emergency in Palliative Care? 1 Palliative Care Emergencies Major haemorrhage Metastatic Spinal Cord Compression (MSCC) Superior Vena

More information

(i) This FAQ does not deal with clinical issues (eg What is the definition of a stroke unit? or

(i) This FAQ does not deal with clinical issues (eg What is the definition of a stroke unit? or STROKE INTEGRATED PERFORMANCE MEASURE RETURN (IPMR) FREQUENTLY ASKED QUESTIONS (FAQ) Prepared by NHS North West, Lancashire & Cumbria Cardiac & Stroke Network, Cheshire and Merseyside Clinical Networks

More information

Dorset Cancer Alliance:

Dorset Cancer Alliance: Dorset Cancer Alliance: - Structure and Functions - SSG specification Where are we without a Network? Wessex Strategic Cancer Network Individual Trust Cancer Services Dorset CCG Specialised Commissioning

More information

Leeds: Early Diagnosis Project updates

Leeds: Early Diagnosis Project updates Leeds: Early Diagnosis Project updates Cancer Cascade Event, 11 th May 2017 Joanna Bayton-Smith, Macmillan Leeds Cancer Strategy, Programme Manager Objectives: To provide overview of Leeds Cancer Strategy

More information

The RAPID Programme Rapid Access to Pulmonary Investigation & Diagnosis

The RAPID Programme Rapid Access to Pulmonary Investigation & Diagnosis Patient Experience National Network Awards (PENNA) The RAPID Programme 2016-2019 Rapid Access to Pulmonary Investigation & Diagnosis Kath Hewitt Lead Clinical Nurse Specialist Ailsa Rowlands Programme

More information

Clinical indications for positron emission tomography

Clinical indications for positron emission tomography Clinical indications for positron emission tomography Oncology applications Brain and spinal cord Parotid Suspected tumour recurrence when anatomical imaging is difficult or equivocal and management will

More information

Promoting Innovative Practice

Promoting Innovative Practice Promoting Innovative Practice Fast-track surgery for pancreatic cancer reduces time to treatment, complications and increases the number of patients undergoing successful surgery 1 Mr Keith Roberts, Consultant

More information

Fixing footcare in Sheffield: Improving the pathway

Fixing footcare in Sheffield: Improving the pathway FOOTCARE CASE STUDY 1: FEBRUARY 2015 Fixing footcare in Sheffield: Improving the pathway SUMMARY The Sheffield Teaching Hospitals NHS Foundation Trust diabetes team transformed local footcare services

More information

NHS Rotherham Clinical Commissioning Group

NHS Rotherham Clinical Commissioning Group NHS Rotherham Clinical Commissioning Group Operational Executive: 2 nd November 2015 Governing Body: 4 th November 2015 Review of Stroke Care Pathway GP Lead: Dr Phil Birks Lead Executive: Keely Firth

More information

Meeting the Future Challenge of Stroke

Meeting the Future Challenge of Stroke Meeting the Future Challenge of Stroke Stroke Medicine Consultant Workforce Requirements 2011 201 Dr Christopher Price BASP Training and Education Committee Stroke Medicine Specialist Advisory Committee

More information

A three month project September December 2016

A three month project September December 2016 Improving Insulin Safety in the Clinical Decision Unit A three month project September December 2016 Sarah Gregory - In-Patient DSN, QEQM Hospital Julie Gammon - Ward Manager, CDU, QEQM Hospital 1 The

More information

2010 National Survey. University College London Hospitals NHS Foundation Trust

2010 National Survey. University College London Hospitals NHS Foundation Trust National Cancer Patient Experience Programme 2010 National Survey University College London Hospitals NHS Foundation Trust Published January 2011 The National Cancer Patient Experience Survey Programme

More information

CUP Investigation and Management Guidelines V1 West Midlands SCN Acute Oncology, MSCC and CUP ERG /PJJ/

CUP Investigation and Management Guidelines V1 West Midlands SCN Acute Oncology, MSCC and CUP ERG /PJJ/ Policy and Guidelines for the Investigation, Diagnosis and management of Patients with malignancy of an Unknown Origin (MUO) and Cancer of an Unknown Primary (CUP) 1 West Midlands Clinical Networks and

More information

APPLYING ENHANCED RECOVERY PRINCIPLES: EARLY TESTING IN UPPER GI CANCER

APPLYING ENHANCED RECOVERY PRINCIPLES: EARLY TESTING IN UPPER GI CANCER APPLYING ENHANCED RECOVERY PRINCIPLES: EARLY TESTING IN UPPER GI CANCER William Allum Consultant Surgeon, Royal Marsden NHS Foundation Trust ? POSSIBLE Major procedure Painful Anastomotic complications

More information

1. The Initial Referral Protocol (09-7A-113)

1. The Initial Referral Protocol (09-7A-113) 1. The Initial Referral Protocol (09-7A-113) REFERRAL PATHWAY: ONCOLOGY AND MALIGNANT HAEMATOLOGY SERVICE SHEFFIELD CHILDRENS NHS FOUNDATION TRUST This document contains information on how to access the

More information

Metastatic Spinal Disease

Metastatic Spinal Disease Metastatic Spinal Disease Mr Neil Chiverton Consultant Spinal Surgeon, Sheffield Objectives The scale and nature of the problem NICE recommendations Surgical decision making Case illustrations Incidence

More information

Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012

Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012 Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012 Version Control This is a controlled document please destroy all previous versions on receipt

More information

Cancer of Unknown Primary

Cancer of Unknown Primary Cancer of Unknown Primary Helen Rickards Acute Oncology and Cancer of Unknown Primary CNS 18 th May 2017 Defining CUP Incidence Patient Pathways getting a diagnosis Patient assessment The patient s perspective

More information

NOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May Status (G / A / R) Status (G / A / R)

NOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May Status (G / A / R) Status (G / A / R) Item 18-13c NOSCAN CLINICAL MANAGEMENT GUIDELINE (CMG) AND NOSCAN CHEMOTHERAPY REVIEW (NCR) STATUS DOCUMENT May 2013 BREAST CANCER MCN: Breast Disease: Breast Document ready to circulate lead to be discussed

More information

Urgent and Emergency Care Lung Cancer Initiative

Urgent and Emergency Care Lung Cancer Initiative Urgent and Emergency Care Lung Cancer Initiative Dr Gavin Anderson Consultant Physician Hull & East Yorkshire Hospitals NHS Trust Unscheduled Care in Hull & East Riding Background Local evaluation Sociodemographics

More information

National Cancer Patient Experience Programme National Survey. Royal National Orthopaedic Hospital NHS Trust. Published September 2014

National Cancer Patient Experience Programme National Survey. Royal National Orthopaedic Hospital NHS Trust. Published September 2014 National Cancer Patient Experience Programme 2014 National Survey Royal National Orthopaedic Hospital NHS Trust Published September 2014 The National Cancer Patient Experience Survey Programme is undertaken

More information

Informatics in the new NHS : PHE and NCIN 9 months on. Nicky Coombes National Cancer Intelligence Network

Informatics in the new NHS : PHE and NCIN 9 months on. Nicky Coombes National Cancer Intelligence Network Informatics in the new NHS : PHE and NCIN 9 months on. Nicky Coombes National Cancer Intelligence Network What was then... Key Funding Accountability Regulation Advice Parliament NICE Department of Health

More information

National Breast Cancer Audit next steps. Martin Lee

National Breast Cancer Audit next steps. Martin Lee National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast

More information

Prostate cancer timed clinical pathways

Prostate cancer timed clinical pathways Prostate cancer timed clinical pathways December 2017 1 Context This document sets out preliminary best practice timed clinical pathways for prostate cancer. It is anticipated that Cancer Alliances will

More information

West Midlands Sarcoma Advisory Group

West Midlands Sarcoma Advisory Group West Midlands Sarcoma Advisory Group Guideline for the Initial Investigation and Referral to Sarcoma Specialist Multi Disciplinary Team for Suspected Sarcoma of Soft Tissue Extremities (limbs and trunk

More information